Showing results (11-20 of 136) with videos related to
Sort By:
Pageof 14
Molecular Pharmacology|November 22, 2022
Insights Into the Differential Desensitization of α4β2 Nicotinic Acetylcholine Receptor Isoforms Obtained With Positive Allosteric Modulation of Mutant ReceptorsRoger L Papke, Clare StokesPharmacological Reviews|July 24, 2021
Therapeutic Targeting of α7 Nicotinic Acetylcholine ReceptorsRoger L Papke, Nicole A HorensteinACS Medicinal Chemistry Letters|October 24, 2017
Anti-inflammatory Silent AgonistsNicole A Horenstein, Roger L PapkeNeuropharmacology|March 9, 2020
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signalingRoger L Papke, Jon M LindstromPharmacological Research|March 20, 2023
Silent agonists for α7 nicotinic acetylcholine receptorsRoger L Papke, Marta Quadri, Alican GulsevinBritish Journal of Pharmacology|August 17, 2002
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysisRoger L Papke, Julia K Porter PapkeTrends in Pharmacological Sciences|June 13, 2015
Looking below the surface of nicotinic acetylcholine receptorsClare Stokes, Millet Treinin, Roger L PapkeACS Chemical Neuroscience|July 8, 2025
The Functional Topology of Phenylpiperazinium Agonists and Antagonists on the Nicotinic Acetylcholine Receptor Landscape: Pointing the Way for Future Therapeutic Management of Inflammation and Neuropathic PainHina Andleeb, Alican Gulsevin, Roger L PapkeMini Reviews in Medicinal Chemistry|February 1, 2020
In Silico Modeling of the α7 Nicotinic Acetylcholine Receptor: New Pharmacological Challenges Associated with Multiple Modes of SignalingAlican Gulsevin, Roger L Papke, Nicole HorensteinBioorganic & Medicinal Chemistry Letters|December 17, 2008
Synthesis of H-bonding probes of alpha7 nAChR agonist selectivityJingyi Wang, Roger L Papke, Nicole A HorensteinPageof 14